Search images on Google Product Monograph
Active Ingredients:
- brentuximab vedotin, 50 MG/VIAL
DIN: 02401347
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: SEAGEN INC.
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FX - (ATC, WHO)
- L01FX05 - BRENTUXIMAB VEDOTIN (WHO)
Pharmaceutical standard: MFR